Pfizer’s COVID-19 Vaccine Filed for Children 5 to 11 in Japan

Pfizer and BioNTech said on November 10 that they have filed an application asking Japanese regulatory authorities to approve the label expansion of their COVID-19 vaccine Comirnaty for use in children aged five through 11. In Japan, Comirnaty was approved...read more